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Objectives. Behavioural and psychological symptoms of dementia (BPSD) cause signiﬁcant distress to both aged care residents and
staﬀ. Despite the high prevalence of BPSD in progressive neurological diseases (PNDs) such as multiple sclerosis, Huntington’s
disease, and Parkinson’s disease, the utility of a structured clinical protocol for reducing BPSD has not been systematically
evaluated in PND populations. Method. Staﬀ (n = 51) and individuals with a diagnosis of PND (n = 13) were recruited into the
study, which aimed to evaluate the eﬃcacy of a PND-speciﬁc structured clinical protocol for reducing the impact of BPSD in
residential aged care (RAC) and specialist disability accommodation (SDA) facilities. Staﬀ were trained in the clinical protocol
through face-to-face workshops, which were followed by 9 weeks of intensive clinical supervision to a subset of staﬀ (“behaviour
champions”). Staﬀ and resident outcome measures were administered preintervention and immediately following the
intervention. The primary outcome was frequency and severity of BPSD, measured using the Neuropsychiatric Inventory-
Nursing Home Version (NPI-NH). The secondary outcome was staﬀ coping assessed using the Strain in Dementia Care Scale
(SDCS). Results. In SDA, signiﬁcant reductions in staﬀ ratings of job-related stress were observed alongside a statistically
signiﬁcant decrease in BPSD from T1 to T2. In RAC, there was no signiﬁcant time eﬀect for BPSD or staﬀ coping; however, a
medium eﬀect size was observed for staﬀ job stress. Conclusions. Staﬀ training and clinical support in the use of a structured
clinical protocol for managing BPSD were linked to reductions in staﬀ job stress, which may in turn increase staﬀ capacity to
identify indicators of resident distress and respond accordingly. Site variation in outcomes may relate to organisational and
workforce-level barriers that may be unique to the RAC context and should be systematically addressed in future RCT studies of
larger PND samples.
1. Introduction
Behavioural and psychological symptoms of dementia
(BPSD) represent a signiﬁcant challenge in the clinical care
and management of individuals living with progressive neu-
rological diseases (PNDs). About 300 per 100,000 people
are aﬀected by the two most common conditions in this
group: multiple sclerosis (MS) and idiopathic Parkinson’s
disease (PD). A further signiﬁcant proportion of people are
aﬀected by Huntington’s disease (6–14 per 100,000) and
motor neurone disease (4–8 per 100,000) [1]. These condi-
tions generally aﬀect individuals from early to late midlife
and are associated with complex patterns of physical, cogni-
tive, and behavioural impairment [2].
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Though the nature and correlates of BPSD in PNDs are
not well characterised, challenging behaviours such as aggres-
sion, irritability, shouting, repetitive questions, and sexual
disinhibition are common and may underlie high rates of
carer distress and burnout in these populations [3]. Not sur-
prisingly, BPSD represent one of several factors that prompt a
decision to move individuals with PNDs into residential facil-
ities, where prevalence of BPSD is also high [4, 5].
In the Australian context, BPSD are linked to stress
and burnout among nursing care staﬀ [6], many of whom
are poorly paid and lack specialist skills required to eﬀec-
tively manage these behaviours [7]. Speciﬁcally, research
shows that inadequate staﬀ training is associated with staﬀ
stress and burnout, which in turn increases risk for resident
BPSD [8, 9].
Additionally, BPSD are costly and resource intensive.
For instance, these symptoms typically prompt referrals
to external support agencies and represent a leading cause
of emergency calls to mental health services [10]. Owing
to the substantial psychosocial and ﬁnancial impact of
BPSD, evidence-based protocols to reduce the impact of
BPSD are required, particularly among PND populations
where the evidence base for nonpharmacological interven-
tions is scarce [11, 12].
BPSD in individuals with PNDs represent a complex
multidimensional construct, likely reﬂecting an interplay of
aetiological factors that precipitate and maintain symptoms.
The complexity of BPSD is reﬂected in recent international
guidelines (e.g., International Psychogeriatric Association
Complete Guide to BPSD [13]), which delineate multiple
aetiologies for BPSD, including genetic, psychosocial, neuro-
biological, medical, and physical factors which interact
dynamically to give rise to challenging behaviours. This
dynamic interplay of variables is particularly salient for indi-
viduals living with progressive neurological diseases, for
whom the onset of symptoms occurs relatively early in life.
Although BPSDs may present in a superﬁcially similar
way across patients, the complex mix of causal factors under-
lying BPSDs in PND populations means that there is
substantial variability in the speciﬁc factors that trigger and
perpetuate BPSDs within the individual patient [14]. In keep-
ing with this model, it follows that addressing case-speciﬁc
causal factors (i.e., using a personalized individual approach)
would be a critical component of an evidence-based
treatment model for BPSD. That is, while genetic and neuro-
biological variables may not be currently treatable, psychoso-
cial and acute/subacute physical and medical factors are
potentially malleable to nonpharmacological interventions.
For instance, factors such as pain or depression [15], loneli-
ness [16], cognitive impairment [17], sensory impairment
[18], overstimulation [19], and even the way personal care
is carried out [20] are all potential contributing factors to
BPSD in PNDs. All these variables represent modiﬁable
targets for individualized, person-centred interventions that
aim at addressing treatable causes of resident suﬀering. In
keeping with this biopsychosocial perspective, Brechin et al.
[21] argue for a stepped-care model of assessment and inter-
vention, which centres on a case-speciﬁc approach to deter-
mine the factors related to BPSD, and implement
appropriate interventions, primarily from a psychosocial
perspective.
In the Australian context, person-centred, nonpharma-
cological treatments for BPSD have received preliminary
support from a recent randomized controlled trial (RCT),
which examined the eﬃcacy of a structured clinical protocol
for managing challenging behaviours in patients with older-
onset dementia [22]. This study found that compared to an
active control condition involving staﬀ training alone, staﬀ
training and concurrent clinical support were associated with
sustained improvements in both staﬀ coping and resident
behaviour. These promising results suggest that compared
to standalone staﬀ training programs which are typically
associated with mixed results [14], there appear to be mea-
surable added beneﬁts of providing concurrent clinical sup-
port in using a structured clinical protocol. Despite these
promising ﬁndings, research is yet to evaluate the utility of
this biopsychosocial model for treating BPSD in individuals
with PNDs in whom BSPDs are often underrecognised and
untreated over a typically protracted disease course.
In addressing this substantial gap in knowledge, we
developed a PND-speciﬁc structured clinical protocol that
emphasised a person-centred, biopsychosocial approach tar-
geting case-speciﬁc causal factors in BPSD in PNDs. In keep-
ing with recent evidence that the beneﬁts of staﬀ training in
BPSD clinical protocols are not maintained in the absence
of clinical support [22], the three-tier training program
involved (i) intensive staﬀ training workshops delivered to
all consenting facility staﬀ; (ii) 9 weeks of intensive clinical
support for a subgroup of facility staﬀ (“behaviour cham-
pions”); and (iii) development and implementation of tai-
lored procedures and resources intended to incorporate
these principles into the organisational policy framework.
“Behaviour champions” received intensive clinical supervi-
sion to implement the structured clinical protocol for resi-
dents living with PNDs. This intensive staﬀ training
program was grounded in the model for treatment of BPSD
outlined by Brechin et al. [21], designed to empower staﬀ
with the skills and knowledge to more eﬀectively manage
the impact of BSPDs, and thus reduce reliance on external
mental health services. A summary of the clinical protocol
is provided in Figure 1, and further details are available from
the corresponding author on request.
Due to the progressive and severely debilitating nature of
PNDs, individuals with these conditions often require access
to residential accommodation facilities that can provide high
levels of specialist care and support. However, in the Austra-
lian context, facilities can diﬀer markedly in terms of organi-
sational culture and model of care, level of staﬀ training and
skills, and staﬀ to resident ratios. Some individuals with
PNDs may have access to specialist disability accommoda-
tion facilities tailored to high care needs of individuals under
the age of 65. These specialist facilities typically beneﬁt from
smaller numbers of beds, higher staﬀ to resident ratios, and
an organisational ethos that promotes community participa-
tion and “living well.” Given the limited availability of spe-
cialist disability accommodation facilities, many people
with PNDs reside in large residential aged care facilities
(RAC), which predominantly cater for older adults (over
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the age of 65) with high dependency needs. These facilities
generally have fewer residents with young-onset PNDs, and
individuals with PNDs typically enter these facilities during
the later stages of illness when their need for physical, social,
and emotional support is greatest [23].
Since diﬀerent residential accommodation settings pres-
ent distinct challenges and opportunities, this study aimed
to evaluate the utility of the structured clinical protocol in
both RAC and SDA. Since intensive training and clinical sup-
port would oﬀer the substantial input required to change the
clinical culture of the RAC, we hypothesised that the inter-
vention would be associated with signiﬁcant reductions in
resident BPSD and improvements in staﬀ coping, in both
the RAC and SDA. The primary outcome measure was
changes in resident BPSD, and the secondary outcome mea-
sure was changes in staﬀ coping.
2. Method
2.1. Participants
2.1.1. Residents. Residents were recruited from a residential
aged care (RAC) facility and a specialist disability accommo-
dation (SDA) facility located in metropolitan Melbourne,
Australia. The RAC comprised 45 beds (including 15 PND-
speciﬁc beds) and 62 direct care staﬀ. The SDA comprised
a 6-bed, PND-speciﬁc facility employing 10 direct care staﬀ.
At both facilities, all residents with a diagnosis of
PND were approached to participate in the study. Resi-
dents provided informed consent after receiving informa-
tion packs detailing the study. Accounting for resident
deaths or removal from facilities during the study, the
ﬁnal sample comprised 13 individuals, 7 residing in the
RAC (M age= 58.29 years, SD=13.74) and 6 in the SDA
(M age= 49.83 years, SD=5.49).
2.1.2. Staﬀ. Staﬀ at each facility were recruited through
project scoping sessions conducted by a registered clinical
neuropsychologist. At project scoping sessions, staﬀ were
provided a verbal summary of the project goals and pro-
cesses, as well as a comprehensive participant information
and consent form. At these meetings, informed written con-
sent was obtained from 51 staﬀ members (RAC: n = 41;
SDA: n = 10).
2.2. Materials
2.2.1. Resident Demographic Data. Demographic data,
including age, gender, time residing at the facility, PND diag-
nosis, and other relevant diagnoses, were obtained from the
residents’ medical ﬁles at preintervention baseline.
2.2.2. Resident BPSD. The Neuropsychiatric Inventory-
Nursing Home Version (NPI-NH) was used to assess the
frequency of BPSD as rated by the behaviour champions.
The NPI-NH is a modiﬁed version of the original Neuro-
psychiatric Inventory [24] designed to measure BPSD
symptoms in geriatric patients. A structured interview
format is used in both instruments to assess 12 areas of
BPSD symptomatology commonly found in dementing
illnesses (i.e., delusions, hallucinations, agitation/aggression,
depression, anxiety, euphoria/elation, apathy/indiﬀerence,
disinhibition, irritability/lability, aberrant motor behaviour,
night-time behaviour, and appetite/eating changes).
Staﬀ provide ratings of symptom frequency and severity,
and rate the degree of organisational disruption (i.e., extra
staﬀ stress and workload) caused by the presenting symp-
toms. Frequency scores range from 0 to 4, and severity scores
range from 0 to 3. A symptom subscale score is calculated
from the product of the severity and the frequency scores
for each domain, with scores ranging from 0 to 12. The
sum of the subscale scores is calculated to form the total
score, ranging from 0 to 144. High scores on each scale rep-
resent a higher level of behavioural symptoms. A major study
on the validity of the NPI-NH has been published [25]. These
researchers demonstrated that licensed vocational nurses
provided more accurate ratings than certiﬁed nurses’ aides,
supporting the use of the patients’ primary nurse (i.e., behav-
iour champion) in the present study.
2.2.3. Staﬀ Demographic and Outcome Measures. Demo-
graphic data, including age, gender, and years worked at
the facility, were obtained at baseline from each participat-
ing staﬀ member. Self-reported conﬁdence, knowledge,
motivation, absenteeism, and use of employee support pro-
grams were measured using an in-house questionnaire.
Training workshops (2 weeks)
(i) Participants: staﬀ n = 51 (RAC = 41; SDA = 10)
(ii) Workshop 1: understanding how progressive brain
(iii) Workshop 2: behaviour management strategies and
(iv) Postworkshop data collection : posttraining
Intensive clinical support (9 weeks)
(i) Participants: behaviour champions n=6
(ii) Workshop: advanced skills in behaviour
(iii) Consolidating behavioural observation (e.g.,
(iv) Structured and targeted information gathering
(v) Developing and implementing targeted behaviour
(vi) Ongoing review of behaviour strategies and
Baseline data collection (time 1)
Postintervention data collection (time 2)
diseases impact thinking, behaviour and emotions
tools
measures of perceived knowledge, skills,
understanding, conﬁdence and motivation.
management
behaviour charting and functional analysis)
strategies (e.g., ﬁle review, patient interviews and
reviewing behaviour charts)
support strategies
problem‐solving barriers to implementation
(RAC=3; SDA = 3)
Figure 1: Timeline and protocol.
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Job strain, not related to speciﬁc residents, was measured
using the 27-item Strain in Dementia Care Scale (SDCS) [7].
This measure was developed speciﬁcally for use in dementia
care settings. The SDCS contains items relating to frustrated
empathy, diﬃculty in understanding residents, balancing
competing needs, balancing emotional involvement with
residents, and perceived lack of appreciation from others.
Staﬀ rated how frequently a situation or feeling related to
care of residents was experienced, from 1 (never/rarely) to
4 (very often), and how much stress the situation or feel-
ing caused when it did occur, from 1 (none/hardly any) to
4 (high stress). A total score was calculated for frequency
of strains and stress associated with items above. Internal
reliability was high in this study, at a = 0 88 for the total
frequency score and a = 0 93 for the total stress score.
All staﬀ outcome measures were completed at prein-
tervention baseline (T1) and immediately following the
11-week intervention program (T2).
2.3. Procedure. Ethics approval for the study was obtained
from Calvary Health Care Bethlehem (CHCB) Human
Research Ethics Committee and Melbourne Health Human
Research Ethics Committee.
We conducted a pilot study to evaluate the utility of a
structured clinical protocol for reducing the impact of BPSDs
in residents living with PND. Data was collected at preinter-
vention baseline, pre- and postworkshop training, and
immediately following the roll-out of the entire 11-week
intervention package which involved facility-wide staﬀ work-
shop training (2 weeks) and an advanced training program
involving a workshop and clinical supervision/support to a
smaller subset of “behaviour champions” (9 weeks). The
intervention protocol is described in the sections that follow
and summarised in Figure 1.
2.3.1. Recruitment. Residents were recruited through
consultation with senior staﬀ at both facilities. The inclu-
sion criteria required a positive diagnosis of progressive
neurological.
2.3.2. Staﬀ Training Workshops. All enrolled staﬀ (n = 51)
attended two ninety-minute training workshop sessions,
which covered core components of the structured clinical
protocol. Pre- and posttraining self-report questionnaires
were administered to all staﬀ that attended training sessions.
Using a four-point Likert scale (1 =none to 4= excellent),
staﬀ rated their perceived knowledge, understanding, skills,
conﬁdence, and motivation to engage in person centred,
context-sensitive behaviour management approaches.
2.3.3. Intensive Clinical Support. A clinical neuropsychologist
experienced in working with BPSD provided an additional
9-week advanced training package for behaviour cham-
pions enrolled at each site. The program involved a 90-
minute advanced training workshop (week 1), followed by
clinical support provided over eight weeks, with supervision
provided weekly for the ﬁrst month and fortnightly for the
second month. Clinical supervision sessions focused on
assisting staﬀ in implementing the structured clinical proto-
col to manage resident BPSD (see Figure 1).
2.4. Data Analysis. All data were analysed using IBM SPSS
22.0 and screened for violations of normality.
Normality plots indicated that primary and secondary
outcome measures (NPI-NH and SDCS, resp.) were nor-
mally distributed, and preliminary analysis indicated no vio-
lation of assumptions across analyses unless otherwise stated.
Site comparisons (RAC versus SDA) were conducted
using independent samples t-tests for the following descrip-
tive variables: resident age, baseline BPSD, staﬀ age, and prior
training. Chi-square analysis was conducted to determine
whether there was sex diﬀerences in residents and staﬀ
between sites. Percentages and frequencies are reported
for the following characteristics: prior training (yes/no). For
primary and secondary outcome analyses, repeated measures
t-tests were conducted for each outcome measure (baseline
T1 scores–postintervention T2 scores) at both sites.
3. Results
3.1. Resident Characteristics. Descriptive statistics for the res-
ident sample are provided in Table 1. Univariate analyses
revealed that the RAC and SDA did not signiﬁcantly diﬀer
on baseline total NPI-NH scores (t 1, 11 = 1 07, p = 0 307),
such that residents at each facility had comparable levels of
BPSD at baseline. No signiﬁcant diﬀerences were identiﬁed
for age or gender.
3.2. Staﬀ Characteristics
3.2.1. Demographics by Site. Descriptive statistics for the staﬀ
sample are provided in Table 2. Groups diﬀered in number of
years worked in the facility, such that RAC staﬀ reported lon-
ger tenure at the facility than those at the SDA. However, this
diﬀerence did not reach statistical signiﬁcance (p = 0 078).
3.2.2. Staﬀ Perceptions of Self and Organisational Eﬃcacy by
Site. Table 2 presents baseline measures of staﬀ self- and
organisational eﬃcacy, as assessed by staﬀ ratings of their
own knowledge, skills, conﬁdence, and motivation to manage
BPSD, in addition to perceptions of organisational eﬃcacy in
addressing BPSD. Staﬀ at the RAC endorsed lower levels of
motivation to manage BPSD (M = 3 46; SD=1.31) than
SDA staﬀ (M = 4 20; SD=0.79); however, the diﬀerence did
not reach statistical signiﬁcance (p = 0 095). Both groups
were comparable on other measures of self-eﬃcacy including
baseline perceptions of knowledge/skills, understanding of
policies/procedure, conﬁdence, and support.
Analysis of staﬀ perceptions of organisational eﬃcacy
revealed signiﬁcant group diﬀerences, such that RAC
staﬀ endorsed lower levels of support from family carers
of residents (p = 0 023). RAC staﬀ also endorsed lower
levels of organisational success in reducing distress in
residents with BPSD; however, this diﬀerence did not
reach statistical signiﬁcance (p = 0 054).
3.3. Workshop Training Outcomes by Site
3.3.1. Workshop 1: Understanding How Progressive Brain
Diseases Impact Thinking, Behaviour, and Emotions. For
RAC, paired t-tests revealed signiﬁcant posttraining increases
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on measures of staﬀ perceived knowledge (p < 0 001), skills
(p = 0 038), understanding (p = 0 001), conﬁdence (p =
0 008), and motivation (p = 0 040) to identify and manage
cognitive, behavioural, and emotional symptoms in people
with progressive neurological diseases. Similarly, staﬀ at the
SDA reported signiﬁcant posttraining increases in knowledge
(p = 0 015), skills (p = 0 040), and motivation (p = 0 041) in
this area of competence. There were no signiﬁcant changes
observed in staﬀ ratings of conﬁdence at the SDA.
3.3.2. Workshop 2: Behaviour Management Strategies and
Tools. For RAC, paired t-tests revealed signiﬁcant posttrain-
ing increases on measures of staﬀ perceived knowledge
(p = 0 002), skills (p = 0 002), understanding (p < 0 001), and
motivation (p = 0 001) in completing behaviour charts
and implementing behaviour support plans. Similarly, staﬀ
at the SDA reported signiﬁcant posttraining increases in
knowledge (p = 0 035); however, increases in perceived
skills did not reach statistical signiﬁcance (p = 0 074).
3.4. Outcomes by Site: BPSD Ratings
3.4.1. RAC. As shown in Table 3, for NPI-NH ratings, there
was no signiﬁcant time eﬀect for BSPSDs from T1 to T2
(t 1, 6 = 1 18, p = 0 283, d = 0 33). Similarly, there was no
signiﬁcant reduction in perceived level of organisational
disruption associated with the behaviours (t 1, 6 = 0 536,
p = 0 611, d = 0 13).
3.4.2. SDA.Analyses of NPI-NH ratings revealed a signiﬁcant
reduction in BPSD from T1 to T2 (t 1, 5 = 2 58, p = 0 049,
d = 0 84). Reductions were also observed in perceived levels
of organisational disruption associated with the behaviours;
however, this change did not reach statistical signiﬁcance
(t 1, 5 = 1 97, p = 0 108, d = 1 13).
3.5. Outcomes by Site: Staﬀ Coping
3.5.1. RAC. Longitudinal analyses of the Strain in Dementia
Care Scale (SDCS) ratings included follow-up data collected
from 25 of the 41 staﬀ (61%) initially enrolled at T1. Analyses
of demographic and psychological characteristics of partici-
pating versus nonparticipating staﬀ at T2 revealed no signif-
icant group diﬀerences in age, gender, or ratings of
motivation, skills, or knowledge as assessed at T1.
As shown in Table 4, no signiﬁcant time eﬀect was
found on the total frequency (of perceived job strains)
scale (t 1, 24 = 1 56, p = 0 131, d = 0 32). Though reductions
in total stress (associated with perceived job strains) did not
reach statistical signiﬁcance (t 1, 24 = 1 77, p = 0 090), a
medium eﬀect size was observed (d = 0 50).
3.5.2. SDA. Longitudinal analyses of the Strain in Dementia
Care Scale (SDCS) ratings included follow-up data collected
from 7 of the 10 staﬀ (70%) initially enrolled at T1. Paired
t-tests revealed no signiﬁcant time eﬀect on the total fre-
quency (of perceived job strains) scale (t 1, 6 = −0 17, p =
0 872, d = 0 12). In contrast, there was a statistically signiﬁ-
cant reduction in total stress (associated with job strains)
from T1 to T2 (t 1, 6 = 2 66, p = 0 045, d = 0 85).
3.6. Additional Analyses by Diagnostic Group. To account for
potential variation in the behavioural proﬁle and disease pro-
gression of MS and non-MS residents, data were reanalysed
after excluding the non-MS residents. We found that exclu-
sion of these residents did not signiﬁcantly alter the results
on the primary NPI-NH outcome measure.
4. Discussion
To our knowledge, this is the ﬁrst study of its kind to evaluate
the eﬃcacy of training and clinical support in implementing
a structured clinical protocol to reduce the impact of behav-
ioural and psychological symptoms of dementia (BPSD) in
progressive neurological diseases (PNDs). Due to the pro-
gressive and severely debilitating nature of PNDs, individuals
with these conditions frequently require access to residential
accommodation facilities that can provide high levels of care
and support. In the Australian context, specialist disability
accommodation facilities are limited, and when access is
not available, these patients are typically placed into general
residential aged care facilities, which often diﬀer markedly
in terms of staﬀ expertise, ethos, and model of care. To
account for these diﬀerences and ensure the generalisability
of ﬁndings, we aimed to evaluate the feasibility and eﬃcacy
of the structured clinical protocol in both residential aged
care (RAC) and specialist disability accommodation (SDA).
Grounded in Brechin et al.’s [21] model of treatment
for BPSD, which emphasises a proactive, person-centred
approach to identifying and targeting contextual environ-
mental causes and risks for BPSD, we expected that the com-
bination of training plus intensive clinical support would
oﬀer the substantial input required to change clinical culture
in both types of facilities. We therefore hypothesised that the
intervention would be associated with signiﬁcant reductions
in BPSD and improvement in staﬀ coping, in both the RAC
and SDA.
Results partially support our expectations. While ﬁndings
provide preliminary support for the feasibility and eﬃcacy of
Table 1: Demographic and behavioural data for PND resident
sample.
Intervention setting
RAC SDA p value
Number of residents
enrolled
7 6 —
Age (SD)
58.29
(13.74)
49.83 (5.49) 0.187
Females, n (%) 5 (71) 6 (100) 0.462
PND diagnosis, n (%)
Multiple sclerosis 5 (72) 6 (100) —
Huntington’s disease 1 (14) — —
Parkinson’s disease 1 (14) — —
Baseline total NPI 19.57 (9.18)
25.67
(11.34)
0.307
Baseline NPI disruption 7.86 (4.26) 8.67 (5.09) 0.760
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a PND-speciﬁc structured clinical protocol, we found that
outcomes markedly diﬀered between intervention settings.
Encouragingly, and in keeping with expectations, we found
that in the SDA setting, the 11-week program was associated
with statistically signiﬁcant reductions in BPSD. Findings
also revealed signiﬁcant improvements in staﬀ coping in
the SDA setting, as indicated by signiﬁcant reductions in total
job-related stress from T1 to T2. Contrary to expectations,
training and intensive clinical support were not associated
with a reduction in BPSD and staﬀ stress at the RAC. Inter-
estingly, while there was no eﬀect of time on BPSD, reduc-
tions in job-related stress approached statistical signiﬁcance.
While the signiﬁcant eﬀect of staﬀ training and intensive
clinical support was found only in the SDA setting, these
results from a small sample of individuals with PNDs have
important clinical and theoretical signiﬁcance. Firstly, these
ﬁndings add to an emerging body of research supporting
the eﬃcacy of nonpharmacological approaches to manage-
ment of BPSD [21, 22]. Since existing research in this area
has been limited only to a single RCT of a structured clinical
protocol for BPSD in individuals with older-onset dementia
of the Alzheimer’s type [22], our ﬁndings extend on this ear-
lier work to suggest that this intervention model may be an
acceptable and eﬃcacious approach to management of BPSD
associated with young-onset PNDs, at least in the SDA
setting.
From a theoretical standpoint, these ﬁndings suggest
that BPSD are amenable to change via context-sensitive,
behaviourally focused approaches that aim to respond to
the individual’s unmet psychological, social, and emotional
needs [11, 21]. As such, based on this data, it seems reason-
able to infer that when delivered in isolation, pharmacologi-
cal approaches are likely insuﬃcient to address the multiple
aetiologies for BPSD in PNDs, including genetic, psychoso-
cial, neurobiological, medical, and physical factors, which
interact dynamically to give rise to a complex constellation
Table 2: Demographic and psychological characteristics of participating staﬀ.
RAC SDA p value
Demographics
N 41 10 —
Age, M (SD) 46.24 (12.55) 43.70 (9.43) 0.552
Tenure (years), M (SD) 8.58 (8.30) 3.77 (2.52) 0.078
Days absent 0.73 (2.54) 0.80 (1.32) 0.935
Baseline perceptions
BPSD self-eﬃcacy total∗ 19.07 (4.08) 19.70 (1.77) 0.639
Training provided 2.95 (0.92) 2.80 (0.63) 0.626
Skills/knowledge 3.10 (0.77) 2.80 (0.63) 0.263
Policy/procedures 3.07 (1.19) 3.20 (0.63) 0.747
Conﬁdence 3.17 (0.70) 3.30 (0.82) 0.616
Motivation 3.46 (1.31) 4.20 (0.79) 0.095
Support 3.32 (0.82) 3.40 (1.17) 0.794
BPSD organisational eﬃcacy total∗ 11.20 (2.74) 13.00 (2.83) 0.069
Reducing frequency 3.00 (0.89) 3.20 (0.63) 0.509
Research driven 2.63 (0.92) 3.00 (1.33) 0.307
Reducing distress 2.93 (0.79) 3.50 (0.97) 0.054
Supported by family/carers 2.63 (0.83) 3.30 (0.68) 0.023
∗ denotes the total score (composite measure) derived from subscales assessing perceived self and organisational eﬃcacy in managing BPSDs.
Table 3: Means, standard deviations, and eﬀect sizes on the NPI-
NH.
T1 baseline
M (SD)
T2 follow-up
M (SD)
Eﬀect
size d
Sig T1-T2
RAC (n = 7)
NPI total 19.57 (9.18) 16.71 (7.87) 0.33 0.283
NPI disrupt 7.86 (4.26) 7.29 (4.35) 0.13 0.611
SDA (n = 6)
NPI total 25.67 (11.34) 16.33 (10.78) 0.84 0.049
NPI disrupt 8.67 (5.09) 4.50 (1.05) 1.13 0.108
Table 4: Means, standard deviations, and eﬀect sizes on the SDCS.
Facility
T1 baseline,
M (SD)
T2 follow-up,
M (SD)
Eﬀect size
d
Sig
T1-T2
RAC
Frequency
of strains
58.80 (7.50) 56.56 (6.27) 0.32 0.131
Total stress 54.04 (12.48) 47.96 (11.64) 0.50 0.090
SDA
Frequency
of strains
48.00 (6.03) 48.67 (5.54) 0.12 0.872
Total stress 46.00 (10.00) 38.33 (7.99) 0.85 0.045
6 Behavioural Neurology
of symptoms that are unique to the individual [3, 21, 22].
Current ﬁndings are also in keeping with recent international
guidelines (e.g., International Psychogeriatric Association
Complete Guide to BPSD, 2012), which suggest that non-
pharmacological treatments may be useful to integrate into
usual care for people with PNDs.
In keeping with expectations, signiﬁcant decreases in
staﬀ job stress at the SDA were observed alongside signif-
icant reductions in resident BPSD. Though the precise
mechanism underlying changes in staﬀ job stress is uncer-
tain, we speculate that reductions in staﬀ stress were medi-
ated by changes in staﬀ perceptions of resident behaviour
[22]. Moreover, in keeping with previous theoretical and
empirical links between staﬀ stress and resident BPSD
[8, 9], results show that PND-speciﬁc training and clinical
support are associated with measurable reductions in staﬀ
stress, which may in turn increase staﬀ capacity to identify
indicators of resident distress and respond accordingly [26].
While perhaps surprising, limited support for eﬀects of
the structured clinical protocol on BPSD in the RAC setting
represents an important ﬁnding. While the absence of a sta-
tistically signiﬁcant eﬀect on BPSD may be at least partly
related to the possibility that staﬀ stress levels did not signif-
icantly change in the RAC [8, 26], site variation in BPSD out-
comes should also be considered in light of organisational
and workforce level barriers that may be unique to the RAC
context. Firstly, due to the standardized nature of the clinical
protocol and constraints on training resources, the number
of staﬀ receiving intensive clinical support (i.e., “behaviour
champions”) was limited to three per intervention setting.
Since the RAC was a substantially larger facility both in terms
of total staﬀ and residents, the behaviour champion to staﬀ
ratio was substantially lower than in the SDA setting. Specif-
ically, compared to the SDA setting in which the ratio of
behaviour champions to staﬀ was 1 : 3, the ratio of 1 : 15 in
the RAC setting conferred considerably less opportunities
for facility staﬀ to observe and model behavioural support
skills learnt by the behaviour champions. Similarly, com-
pared to SDA where the ratio of behaviour champions
to residents was 1 : 2, the lower behaviour champion to
resident ratio in the RAC (i.e., 1 : 15) likely contributed
to reduced opportunities for behaviour champions to
deliver individualised behaviour support and facilitate a
consistent approach to care. Taken together with the lower
behaviour champion to staﬀ ratio, the null results in the
RAC are perhaps not surprising and underscore a need to
consider these factors when implementing future RCTs in
this population.
Secondly, to the best of our knowledge, this study repre-
sents the ﬁrst to systematically measure baseline staﬀ psy-
chological characteristics, which may be another factor
contributing to the observed diﬀerences in outcomes between
sites. Interestingly, staﬀ in RAC endorsed lower levels of
motivation to engage in BPSD management at baseline.
Though the correlates of reduced staﬀ motivation cannot be
established, we speculate that reduced staﬀ motivation may
be intimately associated with the organisational ethos of
RAC, which focuses primarily on alleviating suﬀering and
supporting the end of one’s life [27], rather than engaging
in more active management or neuro-rehabilitation
approaches [23]. As such, in a residential facility where
roles, policies, and procedures are situated within a more
task-oriented framework, it is perhaps not surprising that
staﬀ would assign lesser value and endorse reduced moti-
vation to engage in proactive, person-centred behaviour
management approaches. In contrast, it is noteworthy that
statistically signiﬁcant eﬀects were observed in the setting,
where individually tailored, context-sensitive interventions
are likely considered to align more closely to an organisa-
tional ethos centred on residents “living well” and retain-
ing independence, where staﬀ are encouraged to support
resident participation and independence in daily activities.
Although speculative, the potential impact of these
factors should prompt researchers to consider the inﬂuence
of an organisation’s clinical culture on intervention out-
comes. To systematically address these factors in future
research, targeted strategies and resources are needed to
embed these principles into organisational procedures,
thereby increasing the likelihood that staﬀ will reconceptua-
lise their clinical role and view behaviour management as a
core component of their daily tasks and duties. Accordingly,
adaptations to the current clinical protocol might involve
embedding BSPD management principles into the general
care regime at both intake and clinical handover (i.e., dedi-
cated behaviourmanagement component of clinical handover
and mandatory behaviour charting). Based on anecdotal evi-
dence from the current study, the success of these strategies
will likely require top-down support from senior managers
and staﬀ who have capacity to lead, model, and embed these
systemic changes into the general care regime. The allocation
of appropriate resources (e.g., incentives/organisational rec-
ognition and higher staﬀ : resident ratios) would also be
required to make these feasible recommendations. These
observations are in keeping with meta-analytic evidence that
supportive workplace relations (e.g., support and incentive-
based programs) are a key factor underlying the successful
translation of skills into practice [28].
The current study did have several limitations. Since
resource limitations precluded the possibility of extended
follow-up, further studies are required to establish whether
the observed gains are maintained over time. Furthermore,
longitudinal studies of this nature are prone to sample
attrition, reﬂected in the T2 follow-up rate of staﬀ enrolled
in the study. Despite this weakness, we collected detailed
information on staﬀ demographic and psychological vari-
ables, analyses of which revealed no signiﬁcant diﬀer-
ences between participating and nonparticipating groups
at T2 follow-up.
A further caveat pertains to the intensity and duration
of clinical support for behaviour champions. For instance,
anecdotal evidence suggests that an extended period of clini-
cal support (e.g., 12 months) with increased time between
supervision sessions (e.g., monthly versus weekly sessions)
may have been beneﬁcial and provided additional scope
to embed the structured clinical protocol into organisa-
tional policy and clinical procedures; an approach that
would likely contribute to a more robust shift in organisa-
tional clinical culture.
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Finally, since a large proportion of our sample comprised
individuals living with multiple sclerosis (MS), the generaliz-
ability of our ﬁndings to lower prevalence PNDs (e.g., MND
and PD) is somewhat limited. To account for potential vari-
ation in the behavioural proﬁle and disease progression of
MS and non-MS residents, data were reanalysed after exclud-
ing the non-MS residents. We found that exclusion of these
residents did not signiﬁcantly alter the results on any of
the primary outcome measures. It is also important to
note that despite the large proportion of residents with MS
in this study, the composition of our sample is consistent
with the higher population prevalence of multiple sclerosis,
particularly among those living in residential care facilities
housing individuals under the age of 65 years.
Despite the limitations of the study and the notable
absence of signiﬁcant reductions in BPSD at the RAC setting,
it is noteworthy that training in the RAC was associated with
signiﬁcant increases in staﬀ knowledge, skills, and conﬁdence
from pre- to posttraining. Taken together with evidence that
reductions in staﬀ ratings of job-related stress approached
statistical signiﬁcance (with a medium-to-large eﬀect size),
ﬁndings are in keeping with evidence linking increased
knowledge, skills, and support to reduced likelihood of
stress reactions and staﬀ burnout, which may in turn have
important implications for the frequency and severity of
resident BPSD [6, 8].
5. Conclusions
To our knowledge, this study represents the ﬁrst to evaluate
the feasability and eﬃcacy of a structured clinical protocol
for managing BPSD in PNDs across two distinct residential
accommodation settings. Our results suggest that PND-
speciﬁc training and clinical support in patient-centred care
are associated with beneﬁts for both residents and staﬀ in
SDA. Importantly, while we found that the intervention
was linked to signiﬁcant reductions in staﬀ job stress and res-
ident BPSD in the SDA setting, these eﬀects were not
observed in the RAC. While the nonsigniﬁcant reduction in
staﬀ job stress may at least partly explain the null eﬀect of
the structured clinical protocol on BPSD in the RAC, site var-
iation in BPSD outcomes may relate to organisational and
workforce level barriers that may be unique to the RAC con-
text and should be systematically addressed in future RCT
studies of larger PND samples.
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